GMP BIOMANUFACTURING SERVICES
ABL has a long and proud history providing contract development and GMP biomanufacturing services with a primary focus on viral vectors. ABL has GMP facilities in the USA and Europe to meet your regulatory, geographic preference and redundancy requirements.
ABL offers a comprehensive, phase-specific portfolio of services for the prompt and effective development, manufacturing and testing of viral vectors used in your gene therapy, oncolytic, and vaccine candidates.
YEARS OF EXPERIENCE
ABL promptly delivers your projects employing our decades of experience developing and producing hundreds of GMP batches of a diverse range of viral vectors including AAV, Adenovirus, HSV-1, MVA and others. ABL provides a comprehensive portfolio of services to reduce the need for multiple suppliers.
Focus on your strengths! Here at ABL, we develop and produce advanced therapies because of our extensive experience, multi-decade track record and the market’s need for experts.
ABL’s U.S. location adheres to Good Manufacturing Practice (GMP) standards and is ISO 9001 accredited. ABL Europe’s facility is regularly inspected by the French regulatory authorities (ANSM) and is a GMP licensed site for the manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products in accordance with EMA regulations.